A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
- PMID: 11027423
- PMCID: PMC2363577
- DOI: 10.1054/bjoc.2000.1425
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
Abstract
One hundred and seventy-five children with Stage 3 or 4 neuroblastoma who had obtained a good response to conventional therapy were randomly allocated to 13-Cis retinoic acid at a dose of 0.75 mg/kg/day or placebo for up to 4 years. Toxicity was mild but no advantage in event-free survival was shown for the children receiving retinoic acid.
Copyright 2000 Cancer Research Campaign.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
